BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Arbutus Presents HBV Data at 2017 AASLD Liver Meeting

  The presentations feature multiple Arbutus pipeline programs that highlight the potential of its product candidates and the breadth of its portfolio being advanced to improve current cure rates in chronic HBV.

  October 24, 2017

   · 

  12 min read
• BioMidwest

  SonarMed Completes $3M Series C Preferred Stock Financing

  Proceeds support ongoing controlled market roll-out and launch of the AirWave Monitoring System for pediatric patients.

  October 24, 2017

   · 

  2 min read
• Biotech Bay

  Global Blood Therapeutics Announces Approval of First-in-Class ‘Voxelotor’ as Nonproprietary Name for GBT440

  Voxelotor is an oral, once-daily therapy that is designed to modulate hemoglobin affinity for oxygen and is in clinical development for the treatment of sickle cell disease.

  October 24, 2017

   · 

  5 min read
• Business

  BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization

  The Company has engaged Quintain Project Solutions LLC as the manufacturing project management leader for the PURE EP System.

  October 24, 2017

   · 

  4 min read
• Drug Development

  Sienna Biopharmaceuticals Announces First Patient Dosed in Phase IIb Trial of Topical SNA-120

  The trial has 190 patients with at least moderate pruritus and mild-to-moderate psoriasis.

  October 24, 2017

   · 

  5 min read
• Drug Development

  Rhizen Pharmaceuticals S.A. Announces Preclinical Data Presentations for RP4010, a Novel First-in-Class Oral Small Molecule Inhibitor of Calcium Release-Activated Calcium (CRAC) Channel at 2017 AACR-NCI-EORTC International Conference, USA

  October 24, 2017

   · 

  2 min read
• Drug Development

  U.S. FDA Grants Orphan Drug Designation To Zealand Pharma’s Glepaglutide for the Treatment of Short Bowel Syndrome

  Glepaglutide is a Zealand-invented long-acting GLP-2 analog that may offer a treatment option for patients with reduced or complete loss of intestinal function.

  October 24, 2017

   · 

  2 min read
• Policy

  ContraVir Pharmaceuticals Announces National Institutes of Health Funded Study on Antiviral Activity of CRV431

  ContraVir will utilize preclinical services from the NIAID to characterize the antiviral activity of CRV431 in a humanized mouse model of hepatitis B virus infection.

  October 24, 2017

   · 

  4 min read
• Business

  BioCryst to Announce Third Quarter 2017 Financial Results on November 7

  BioCryst will host a conference call and webcast at 11:00 a.m. ET to discuss financial results and to provide an update regarding the Company’s clinical development programs.

  October 24, 2017

   · 

  1 min read
• Business

  Nicox Provides Third Quarter 2017 Business Update and Cash Position

  Nicox updated on its activities and cash balance as of September 30, 2017.

  October 24, 2017

   · 

  7 min read